Randomised controlled trial of mesalazine in IBS

Salmonella Gastroenteritis During Childhood Is a Risk Factor for Irritable Bowel Syndrome in Adulthood

(2014) Cesare Cremon et al.   GASTROENTEROLOGY

The placebo response in medicine: minimize, maximize or personalize?

(2013) Paul Enck et al.   NATURE REVIEWS DRUG DISCOVERY

FDA and EMA end points: which outcome end points should we use in clinical trials in patients with irritable bowel syndrome?

(2013) M. Corsetti et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα

(2012) Caroline Swan et al.   GUT

Intestinal microbiota in functional bowel disorders: a Rome foundation report

(2012) Magnus Simrén et al.   GUT

Submucous rather than myenteric neurons are activated by mucosal biopsy supernatants from irritable bowel syndrome patients

(2012) S. Buhner et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons

(2012) B. Balestra et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Combination of Allergic Factors Can Worsen Diarrheic Irritable Bowel Syndrome: Role of Barrier Defects and Mast Cells

(2011) M Vivinus-Nébot et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Intestinal Serotonin Release, Sensory Neuron Activation and Abdominal Pain in Irritable Bowel Syndrome

(2011) Cesare Cremon et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Impaired Uptake of Serotonin by Platelets From Patients With Irritable Bowel Syndrome Correlates With Duodenal Immune Activation

(2011) Stephen Foley et al.   GASTROENTEROLOGY

Association of TNFSF15 polymorphism with irritable bowel syndrome

(2011) M. Zucchelli et al.   GUT

Guidelines for the management of inflammatory bowel disease in adults

(2011) C. Mowat et al.   GUT

Two Randomized Trials of Linaclotide for Chronic Constipation

(2011) Anthony J. Lembo et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Immune System in Irritable Bowel Syndrome

(2011) Giovanni Barbara et al.   Journal of Neurogastroenterology and Motility

Aminosalicylates and Other Anti-Inflammatory Compounds for Irritable Bowel Syndrome

(2010) Giovanni Barbara et al.   DIGESTIVE DISEASES

The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome

(2010) T. K. Klooker et al.   GUT

Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study

(2009) R. CORINALDESI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale

(2009) B. SPIEGEL et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mucosal Immune Activation in Irritable Bowel Syndrome: Gender-Dependence and Association With Digestive Symptoms

(2009) Cesare Cremon et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Activation of Human Enteric Neurons by Supernatants of Colonic Biopsy Specimens From Patients With Irritable Bowel Syndrome

(2009) Sabine Buhner et al.   GASTROENTEROLOGY

Postinfectious Irritable Bowel Syndrome

(2009) Robin Spiller et al.   GASTROENTEROLOGY

Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators

(2008) T Piche et al.   GUT